StockClub

LIMN

LIMNLiminatus Pharma, Inc. Class A Common Stock$ --
Liminatus Pharma, Inc. Class A Common Stock

Liminatus Pharma, Inc. Class A Common Stock

LIMN

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 05/15/2026FY2026 Q1
Revenue
0M USD
YoY -
Operating Income
-1M USD
YoY -431624.7%
Net Income
-1M USD
YoY -440572.2%
EPS
-0.05$
YoY +98.1%

Revenue

$0
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$0
$0
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
FY2025 Q4$0
$0
Q4
FY2026 Q1$0
$0
Q1
Actual
$0 (-)

Net Income

$-1.1M
FY2024 Q2$-2.3M
$-2.3M
Q2
FY2024 Q3$-2.9M
$-2.9M
Q3
FY2024 Q4$-3.8M
$-3.8M
Q4
FY2025 Q1$-255
$-255
Q1
FY2025 Q2$113,032
$113,032
Q2
FY2025 Q3$-1.7M
$-1.7M
Q3
FY2025 Q4$-9.9M
$-9.9M
Q4
FY2026 Q1$-1.1M
$-1.1M
Q1
Actual
$-1.1M (-440572.2%)

Surprise History

Actual RevenueAnalyst Estimate
FY2021
Actual:$0
FY2021
$0
FY2022
Actual:$0
FY2022
$0
FY2023
Actual:$0
FY2023
$0
FY2024
Actual:$0
FY2024
$0
FY2025
Actual:$0
FY2025
$0

Analyst Estimates

No forecast data

Earnings Release History